33 Percent of Cancers Aids Related

Aids related cancers namely Kaposi Sarcoma, Cervical Cancer, Non-Hodgkins Lymphoma and Squamous Cell Carcinoma of the conjunctiva continue to occupy high positions in cancer rankings, according to Zimbabwe National Cancer Registry report.

AIDS related cancers remain a public health concern with cervical cancer increasing on a yearly basis from 2005-2015.

“The three of the HIV related Cancers make up 33% of all the cancer cases with cervical cancer cases being 19%, Kaposi Sarcoma and Non-Hudgkin Lymphoma were 7% and 6% of the total cancer cases respectively while the Squamous Cell Carcinoma of the Conjunctiva are part of the other Cancers that make up 34% of Cancer cases,” reads the report.

However Kaposi Sarcoma deaths have fallen, thanks to the availability of Antiretroviral Therapy (ART) which suppresses manifestations of AIDS in HIV positive clients.

The Ministry of Health and Child Care (MoHCC) recognized the link between treatable HIV disease and increased morbidity and mortality from Non Communicable Diseases NCDs that include cancer and has therefore joined other partners to fight this scourge.

The supply of ARVs has led to the recovering of many patients thus reducing the incidence of HIV related cancers.

The Ministry has also embarked on an expansion drive for cervical cancer screening among HIV positive women at most Opportunistic Clinics with support from its strategic partners.

Anti-Cancer drugs such as Bleomycin, Methotrexate, Cisplatin and Doxorubin have been distributed.

Meanwhile the ministry works with its partners to roll out community mobilization and cancer screening programmes in different Districts.

Source :

Check Also

Zimbabwe: U.S.-Based Zim Born Travel Agent Marketing Local Tourism to World Executives

Victoria Falls — Zimbabwe-born and US-based tourism agent, Deborah Calmeyer has taken it upon herself …

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This function has been disabled for Zimbabwe Today.